Mutant p53 has been shown to trigger in cancer cells the MVP, leading to the aberrantly activation of YAP, an essential oncogene for cancer initiation/growth of most solid tumors, including PCa, an effect that can be reverted by statins [46]. This evidence concerns the gene TP53 and cancer.